SSSilvana Soléo Ferreira dos Santos

Silvana Soléo Ferreira dos Santos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Silvana Soléo Ferreira dos Santos has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ação in vitro de extratos de Arrabidaea chica sobre Candida albicans

    by Sandra Berla, Ana Paula Lima Guidi Damasceno, Mariella Vieira Pereira Leão, Silvana Soléo Ferreira dos Santos

    Evidence of the inhibitory action on Candida yeasts by substances that present low or none toxicity to humans, especially substances extracted from plants already used in popular medicine, has been the intention of many researches. The objective of the present work was to determine the in vitro inhibitory activity of extracts of Arrabidaea chica on C. albicans and quantify the number of components present in the extracts. The minimum inhibitory concentration (MIC) of aqueous and hydroalcoholic extracts, autoclaved and filtered, was determined by agar dilution on twenty-five strains of C. albicans and the separation of extract components (solid-aqueous mixing), by thin layer chromatography (TLC). Both the autoclaved hydroalcoholic extract and the filtrated one inhibited all C. albicans strains, in the concentration of 20%. The autoclaved aqueous extract inhibited 84% of the strains at the concentration of 30% while the filtrated didn’t showed inhibitory effect up to a concentration of 50%. The TLC of the autoclaved hydroalcoholic extract evidenced the presence of seven components and the autoclaved aqueous one, two. The hydroalcoholic and aqueous extracts of A. chica presented inhibitory activity on C. albicans, however the hydroalcoholic extract showed superior performance and greater number of components.


  • Inflammatory markers in saliva for diagnosis of sepsis of hospitalizes patients

    by Luciana Freitas Galhardo, Gilson Fernandes Ruivo, Luciane Dias de Oliveira, Graziele Parize, Silvana Soléo Ferreira Dos Santos, Debora Pallos, Mariella Vieira Pereira Leão

    Background: Inflammatory/immunological serum markers are useful for the early detection of organ dysfunction, helping the diagnosis of sepsis. Although the detection of blood biomarkers is a standard practice, the use of noninvasive samples (eg saliva) would be beneficial.Aim: To investigate the saliva of hospitalized patients with and without sepsis and identify the levels of inflammatory markers such as C‐reactive protein (CRP), procalcitonin (PCT), interleukin 6 (IL‐6) and nitric oxide (NO).Methods: Saliva samples were collected from 26 patients in intensive care unit with diagnosis of sepsis and from 26 without sepsis (control). The levels of CRP were determined by using latex agglutination test, whereas those of procalcitonin and IL‐6 by ELISA and NO by the Griess reaction.Results: Of 26 patients with sepsis, 14 were males (54%) with a mean age of 63.81 ± 3.48 years. The control group had the same distribution for gender, with mean age 65.04 ± 4.07 years. Sepsis group showed higher salivary concentrations of CRP, PCT, IL‐6 and NO, with only levels of IL‐6 being statistically different (P = .0001).Conclusions: Patients with sepsis had significantly higher levels of IL‐6 in their saliva, suggesting that this biological sample could be useful in the diagnosis of this condition.


  • Open Access

    IgA antibodies against Streptococcus mutans in breast milk and saliva: Passive Immunity against caries

    by Werônica Jaernevay Silveira Mitterhofer, Alexandre Prado Sherma, Silvana Soléo Ferreira Dos Santos, Mariella Vieira Pereira Leão

    Objective: The present work aimed to correlate the levels of IgA antibodies reactive with Streptococcus mutans antigens in the saliva and/or in the breast milk and the oral health of lactating. Material and methods: Breast milk and whole saliva samples were collected from 29 lactating. The oral health was verified using DMF scores and the volunteers were separated in three groups: 1) low DMF score; 2) high DMF score with active caries and 3) high DMF score without active caries. The IgA antibodies anti-Streptococcus mutans were analyzed in the samples using ELISA technique. Results: The results showed similar levels of IgA antibodies in all groups, both in milk and saliva. No correlation could be confirmed between the levels of IgA in the saliva and in the breast milk with the oral health of lactating studied. Conclusion: The results suggest that, independently of mother’s oral health, the newborn receive the same amounts of anti-Streptococcus mutans IgA by breastfeeding.

  • Open Access

    Matricaria Recutita Extract (Chamomile) to reduce Candida Albicans and Entrobacter Cloacae biofilms: in vitro study

    by Maitê Alves Pequeno, Marissa Rodrigues Silvestre, Isabela Amêndola, Célia Regina Gonçalves e Silva, Mariella Vieira Pereira Leão, Silvana Soleo Ferreira dos Santos

    Objective: This research study aimed at evaluating the inhibitory activity of Matricaria recutira (chamomile) hydroalcoholic extract on Candida albicans and Enterobacter cloacae biofilms. Methods: C. albicans and E. cloacae biofilms with thirty-hour formation were submitted, for five minutes, to 100, 200 and 300 mg / mL of M. recutita hydroalcoholic extract, chlorhexidine digluconate 0.12% (Periogard® - inhibition control) or sterile distilled water (growth control). Subsequently, they were washed and divided into two groups to determine the microbial viability: G/UFC - counting of colony forming units (cfu) in agar and G/DNA - quantification of viable DNA with violet crystal dye by spectrophotometry. Results: M. recutita extract at 300 mg/mL reduced significantly (p <0.01) the E. cloacae cfu/mL number in biofilm with results similar to chlorhexidine 0.12%, while extracts at 100 and 200 mg/mL did not have the same effectiveness. The amount of E. cloacae viable DNA was reduced (p <0.05) in all the M. recutita extract concentrations and chlorhexidine. There was no significant difference (p = 0.565) in the cfu/mL number or in the amount of viable DNA (p = 0.8094) in C. albicans biofilm when compared to untreated biofilm (control) or, even, between the extracts when compared to each other or to chlorhexidine 0.12%. Conclusion: 300 mg/mL M. recutita extract reduced significantly the E. cloacae biofilm but not the C. albicans, both with a similar result to chlorhexidine 0.12% (Periogar®).


  • Lactobacillus rhamnosus intake can prevent the development of Candidiasis

    by Mariella Vieira Pereira Leão, Talita Angelina Aureliano Tavares, Célia Regina Gonçalves e Silva, Silvana Soleo Ferreira dos Santos, Juliana Campos Junqueira, Luciane Dias de Oliveira, Antonio Olavo Cardoso Jorge

    This study aimed to investigate the influence of Lactobacillus rhamnosus intake on the development of candidiasis and cytokines release.


  • Open Access

    Prevalence and Sensitivity of Bacilli and Pseudomonas in the Newborn’s Oral Cavity

    by Priscila Vitor Alves Ferreira, Isabela Amêndola, Luciane Dias de Oliveira, Célia Regina Gonçalves e Silva, Mariella Vieira Pereira Leão, Silvana Soléo Ferreira dos Santos

    The aim of this study was to isolate Enterobacteria and Pseudomonas from the oral cavity of hospitalized newborns (NB) and determine their prevalence and the sensitivity profile to most commonly used antibiotics for this age group. Samples from the oral cavity of NB from 24 to 48 h age were collected using swabs. The samples were inoculated on MacConkey agar, incubated and the colonies counted and identified. For each strain, the minimum inhibitory concentration (MIC) was determined using agar dilution test. Tests for enterobacteria producing extended spectrumβ-lactamases (ESBL) were performed using agar diffusion. Descriptive statistics was used for data analysis. Two of the isolated strains were submitted to the susceptibility test in biofilm. Of the collected samples, 8% presented Enterobacteria (mean of 6,141 CFU/mL) and no Pseudomona species was isolated. Positive samples were from NB in accommodation set or in the NB nursery. Enterobacter was the most prevalent genus and some strains were resistant to ampicillin, gentamicin and cephalothin. No ESBL strain was detected. Microorganisms in biofilms were resistant to all antibiotics, with concentrations four times higher than MIC. The presence of enterobacteria in the oral cavity of newborns, especially some strains resistant to normally used antibiotics, warns to the need for care to avoid the early colonization of this niche and the occurrence of a possible hospital infection in this age group.


  • Lactobacillus is able to alter the virulence and the sensitivity profile of Candida albicans

    by V.M.C. Oliveira, S.S.F. Santos, C.R.G. Silva, A.O.C. Jorge, M.V.P. Leão

    The study investigated whether the interaction with Lactobacillus rhamnosus (ATCC7469) interfere with the expression of virulence factors by Candida albicans (ATCC18804). These micro-organisms were grown in biofilms for 24, 48 and 72 h, Candida was isolated and the expression of the major virulence factors were investigated. The production of phospholipase, protease and haemolysin were observed in appropriate media; observation of germ tubes formation in serum; biofilm formation, after growth in microtitre plates and reading in spectrophotometer. Candida was also tested for antifungal sensitivity to amphotericin B, fluconazole and ketoconazole. The results were compared with the cells of Candida grown in the absence of lactobacilli (control group). Candida cells, which interacted with Lact. rhamnosus (test group), showed significantly lower proteinase and haemolysin activity, when compared with control group. The germ tube formation and biofilm formation capacity also decreased in tested groups, which demonstrated alterations in susceptibility to antifungal drugs. The results suggest that Lact. rhamnosus is able to influence the expression of virulence factors by C. albicans and can alter its antifungal sensitivity profile. These results suggest reduction in the pathogenicity of Candida and improvement in candidiasis therapy and control.


  • Open Access

    Relationship between the probiotic Lactobacillus rhamnosus and Enterococcus faecalis during the biofilm formation

    by Esteban Matias Montecinos Felipe, Machado Jofre Fanny, Amendola Isabela, Regina Goncalves Celia, Vieira Pereira Leao Mariella, Soleo Ferreira Dos Santos Silvana

    One of the factors that make the treatment of Enterococcus faecalis infections difficult is their ability to form biofilm, as well as their natural and acquired resistance to antibiotics which does not have specific drugs for their inhibition. This fact makes essential the search for alternative treatments, as the use of probiotics strains of Lactobacillus rhamnosus has been effective in the treatment of some diseases. In this investigation, the relationship between the probiotic strain of L. rhamnosus and E. faecalis during the biofilm formation was analyzed. Standardized suspensions used in biofilm development and treatment in different stages of the biofilm formation were prepared. The L. rhamnosus suspension was placed in contact for 90 min with E. faecalis freshly created biofilms (initial adherence) in the 24 h biofilms. The same was made with E. faecalis suspension on L. rhamnosus biofilms. L. rhamnosus showed no inhibitory effects on E. faecalis biofilms formation, with an increase in the counting of colony forming units in the treated groups (p=0.0047, p=0.0060). About the L. rhamnosus biofilms, there was no significant difference for both treatment stages. The probiotic strain interfered in vitro with the E. faecalis biofilm formation, thereby intensifying the growth of E. faecalis biofilm. Key words: Enterococcus faecalis, Lactobacillus rhamnosus, biofilm, virulence factor, probiotic.


  • Open Access

    Lactobacillus rhamnosus pode alterar a virulência de Candida albicans

    by Mariella Vieira Pereira Leão, Célia Regina Gonçalves e Silva, Silvana Soléo Ferreira dos Santos, Poliana Gasparin Correa Leite

    Palavras-Chave: Lactobacillus; Candida; Técnicas in vitro ; Candidíase


  • Open Access

    Stability of antimicrobial activity of peracetic acid solutions used in the final disinfection process

    by Solange Alves da Silva Costa, Olívia Ferreira Pereira de Paula, Célia Regina Gonçalves e Silva, Mariella Vieira Pereira Leão, Silvana Soléo Ferreira dos Santos

    The instruments and materials used in health establishments are frequently exposed to microorganism contamination, and chemical products are used before sterilization to reduce occupational infection. We evaluated the antimicrobial effectiveness, physical stability, and corrosiveness of two commercial formulations of peracetic acid on experimentally contaminated specimens. Stainless steel specimens were contaminated with Staphylococcus aureus, Escherichia coli, Candida albicans, blood, and saliva and then immersed in a ready peracetic acid solution: 2% Sekusept Aktiv (SA) or 0.25% Proxitane Alpha (PA), for different times. Then, washes of these instruments were plated in culture medium and colony-forming units counted. This procedure was repeated six times per day over 24 non-consecutive days. The corrosion capacity was assessed with the mass loss test, and the concentration of peracetic acid and pH of the solutions were measured with indicator tapes. Both SA and PA significantly eliminated microorganisms; however, the SA solution was stable for only 4 days, whereas PA remained stable throughout the experiment. The concentration of peracetic acid in the SA solutions decreased over time until the chemical was undetectable, although the pH remained at 5. The PA solution had a concentration of 500-400 mg/L and a pH of 2-3. Neither formulation induced corrosion and both reduced the number of microorganisms (p = 0.0001). However, the differences observed in the performance of each product highlight the necessity of establishing a protocol for optimizing the use of each one.